SecBot SecBot
Insider Cluster (4 insiders) ·Filed May 1, 2026

SYRE

Spyre Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago
Insider cluster: 4 insiders, $2.9M total
Actionable Insight • Neutral

The insider selling is routine in both dollar amount and proportion to market cap. No single insider sold a material stake. The cluster does not signal distress or a negative catalyst, it is consistent with normal portfolio diversification after a strong stock run. Monitor for any unexpected insider buying or a sudden increase in selling volume, but no immediate action is warranted.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$69.42
T+0 close · Apr 30, 2026 · via day close
Latest settled
+43.99%
T+60 · $99.96
Vs SPY
+40.92%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 1 $69.42entry
  2. T+1 · 7mo ago −0.42%α −0.08% · $69.13
  3. T+5 · 6mo ago +8.10%α +5.76% · $75.05
  4. T+20 · 6mo ago +1.61%α −3.67% · $70.54
  5. T+60 · 4mo ago +43.99%α +40.92% · $99.96
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Four insiders at Spyre Therapeutics, including the CEO, CFO, and CMO, sold a total of $2.92M in open-market sales over a 7-day window ending May 8, 2026. The sales follow a Q1 earnings report showing a wider net loss of $69.0M, though the company highlighted positive Phase 2 data and a strong cash runway. The cluster value represents ~0.05% of the $6.3B market cap, which is trivial and routine for a biotech of this size.

Key Financial Metrics

Direction
selling
Total Value
$2.9M
Insiders
4

Key Facts

  • Four insiders sold shares totaling $2.92M in open-market transactions from May 1-8, 2026.
  • CEO Turtle Cameron sold $369K, CFO Scott Burrows sold $892K, CMO Sheldon Sloan sold $1.48M, and Director Michael Henderson sold $174K.
  • Total cluster value is ~0.05% of SYRE's $6.3B market cap, well below the 0.1% materiality threshold.
  • Sales occurred 4 days after Q1 2026 earnings reported a net loss of $69.0M, wider than the $44.8M loss in Q1 2025.
  • The company has a pro forma cash position of $1.18B following a $463M public offering, with runway into H2 2029.
  • Prior 30-day insider activity included $2.9M in sells, consistent with routine insider selling patterns.

Financial Impact

Insider sales of $2.92M represent 0.05% of market cap, immaterial from a capital markets perspective.

dilution

Risk Factors

  • Insider selling could accelerate if the stock continues to rally or if pipeline data disappoints.
  • Wider net losses and pre-revenue status mean the stock is highly sensitive to clinical trial outcomes.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
96% bullish (23 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-SYRE-1778290336581

Track record

36 reports on SYRE

Performance horizon

8 of 12 bullish or bearish reports moved the stock their way by T+60. Best: +54.27% at T+60 after the Apr 13, 2026 report. 15 of 21 went positive at some point.

Filters
  1. Nov 3, 202613d ago 8-K Neutral 5/10 No price data
  2. Nov 3, 202613d ago Press Release Bearish 5/10 Entry $99.04 Now $99.37 −0.33% settles Feb 2
  3. Oct 12, 20265w ago Institutional Cluster Bullish 4/10 Entry $85.90 Now $99.37 +15.68% settles Jan 7
  4. Oct 9, 20265w ago SC 13D/A Neutral 3/10 Entry $85.90 Now $99.37 +15.68% settles Jan 7
  5. Oct 7, 20265w ago 8-K Bearish 5/10 Entry $80.85 Now $99.37 −22.91% settles Jan 4
  6. Oct 6, 20265w ago 424B5 Bearish 6/10 Entry $80.85 Now $99.37 −22.91% settles Jan 4
  7. Oct 5, 20266w ago Press Release Bearish 6/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
  8. Oct 5, 20266w ago 424B5 Bearish 5/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
  9. Oct 5, 20266w ago Press Release Bearish 5/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
  10. Oct 2, 20266w ago Insider Cluster Bearish 4/10 Entry $92.72 Now $99.37 −7.17% settles Dec 30
Showing 10 of 36

US Market Status

Market Closed · Opens Wed (10h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 8, 2026